PTK2 and neoplasm: The FAK inhibitor SK2256098 attenuates the proliferation, motility, and survival of pancreatic cancer cells in vitro [194], while VS-4718 doubled the survival of tumor-bearing mice by restoring sensitivity to chemotherapy and immunotherapy [30, 195].